KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Merck (MRK) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $2.32.

  • Merck's EPS (Basic) rose 8560.0% to $2.32 in Q3 2025 from the same period last year, while for Sep 2025 it was $7.57, marking a year-over-year increase of 5803.76%. This contributed to the annual value of $6.76 for FY2024, which is 472857.14% up from last year.
  • Merck's EPS (Basic) amounted to $2.32 in Q3 2025, which was up 8560.0% from $1.76 recorded in Q2 2025.
  • In the past 5 years, Merck's EPS (Basic) ranged from a high of $2.32 in Q3 2025 and a low of -$2.35 during Q2 2023
  • For the 5-year period, Merck's EPS (Basic) averaged around $1.26, with its median value being $1.49 (2021).
  • In the last 5 years, Merck's EPS (Basic) plummeted by 25064.1% in 2023 and then skyrocketed by 40204.08% in 2024.
  • Over the past 5 years, Merck's EPS (Basic) (Quarter) stood at $1.49 in 2021, then decreased by 20.81% to $1.18 in 2022, then crashed by 141.53% to -$0.49 in 2023, then surged by 402.04% to $1.48 in 2024, then skyrocketed by 56.76% to $2.32 in 2025.
  • Its EPS (Basic) was $2.32 in Q3 2025, compared to $1.76 in Q2 2025 and $2.01 in Q1 2025.